| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |